Randomized double-blind controlled study of Qmaitongguan granule intervention on myocardial perfusion after acute myocardial infarction and reperfusion based on myocardial magnetic resonance technology

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) With the diagnosis of ST-segment elevation acute myocardial infarction, PCI reperfusion therapy is performed within the time window;
•(2) Aged 18-75 years;
•(3) Volunteer to participate in this study and have signed an informed consent form;
•(4) Have a correct understanding of the significance of drug research, and have a good compliance with the observation and evaluation of researchers.

•(1) Patients with severe cardiogenic shock at the time of inclusion;
•(2) Patients with suffered cardiac arrest before enrollment and had been undergoing cardiopulmonary resuscitation for a long time;
•(3) Patients with cardiac complications such as papillary muscle rupture and ventricular septal perforation;
•(4) Aortic dissection patients;
•(5) Patients with severe liver, kidney, nerve, and coagulation dysfunction;
•(6) Patients with severe infection;
•(7) Pregnant or lactating women;
•(8) Patients who participated in other Chinese medicine clinical studies within three months;
•(9) Those who are allergic to contrast media or the drug components of this study.

发起方

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine